Verteporfin photodynamic therapy for central serous chorioretinopathy

Not Applicable

• Conditions: Central serous chorioretinopathy

• Registration Number: JPRN-UMIN000020677
• Lead Sponsor: Kansai Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-02-01
• Study Completion: 2021-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

patients with other retinal diseases photosensitivity

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Visual acuity

Secondary Outcome Measures

Name	Time	Method
central retinal thickness central choroidal thickness